ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BVX Bivictrix Therapeutics Plc

10.00
0.00 (0.00%)
02 Jan 2025 - Closed
Delayed by 15 minutes

Bivictrix Therapeutics Financial Summary

The current BVX market cap is 8.25M. The company's latest EPS is GBP -0.0308 and P/E is -3.25.

Year End 31 December 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 031k000
Operating Income -526k-509k-1.89M-2.98M-3.03M
Net Income -409k-425k-2.34M-2.5M-2.55M
Year End 31 December 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Assets 266k1.07M6.88M4.54M4.3M
Total Liabilities 86k1M554k579k758k
Total Equity 180k67k6.33M3.96M3.54M

Cash Flow

Year End 31 December 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Operating -357k-166k-1.79M-2.4M-1.96M
Investing N/A -63k-46k-379k17k
Financing 275k962k7.03M N/A 1.94M
Market Cap 8.25M
Price to Earnings Ratio -3.25
Price to Sales Ratio 0
Price to Cash Ratio 2.52
Price to Book Ratio 2.33
Dividend Yield -

Share Statistics

Shares Outstanding 82.53M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -4.76%
52 Week High 13.00
52 Week Low 7.50
Spread (Intraday) 1 (10.53%)

Company Info

Company Name Bivictrix Therapeutics Plc
Address c/o slater heelis limited
manchester M3 2ER
Website https://www.bivictrix.com
Industry coml physical, biologcl resh (8731)